Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Effects of Noninvasive Brain Stimulation Techniques on BDNF Levels

NCT: NCT02652832 · TERMINATED

NCT IDNCT02652832
StatusTERMINATED
Start Date2010-12
Completion2017-10-11
SponsorHôpital le Vinatier (OTHER)
First posted
Last updated

Brief Summary

The aim of this study is to investigate the effects of non invasive brain stimulation - NIBS - techniques (Electroconvulsivotherapy - ECT, transcranial Direct Current Stimulation - tDCS, repetitive transcranial magnetic stimulation - rTMS) on serum Brain Derived Neurotrophic factor (BDNF) levels in patients with depression and schizophrenia. Four blood samples will be collected in each participants, one before the NIBS sessions, and 3 after the completion of NIBS protocols: one immediately after the end of the NIBS sessions, a second one week after and a last one month after. Two blood samples separated by one month will also be collected in a a group of healthy volunteers.

Frequently Asked Questions

What is Effects of Noninvasive Brain Stimulation Techniques on BDNF Levels?

Effects of Noninvasive Brain Stimulation Techniques on BDNF Levels is a clinical trial registered under NCT02652832. Current status: TERMINATED.

What is the status of NCT02652832?

The current status of NCT02652832 (Effects of Noninvasive Brain Stimulation Techniques on BDNF Levels) is: TERMINATED.

When did Effects of Noninvasive Brain Stimulation Techniques on BDNF Levels start?

Effects of Noninvasive Brain Stimulation Techniques on BDNF Levels started on 2010-12.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.